{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "17543340",
  "DateCompleted": {
    "Year": "2008",
    "Month": "05",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "11"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2007",
        "Month": "05",
        "Day": "31"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0022-4804",
      "JournalIssue": {
        "Volume": "146",
        "Issue": "1",
        "PubDate": {
          "Year": "2008",
          "Month": "May",
          "Day": "01"
        }
      },
      "Title": "The Journal of surgical research",
      "ISOAbbreviation": "J Surg Res"
    },
    "ArticleTitle": "Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.",
    "Pagination": {
      "StartPage": "32",
      "EndPage": "42",
      "MedlinePgn": "32-42"
    },
    "Abstract": {
      "AbstractText": [
        "We examined expression patterns of matrix metalloproteinase (MMP), tissue inhibitor of metalloproteinase (TIMP), and reversion-inducing cysteine-rich protein with Kazal motifs (RECK) in colorectal cancer tissues to assess their prognostic significance.",
        "mRNA expressions of 17 MMPs, 4 TIMPs, and RECK were measured in 112 colorectal cancerous tissues, 20 normal mucosa tissues, and 11 metastatic liver lesions by real-time reverse-transcriptional-polymerase chain reaction. The protein level expressions were confirmed with immunohistochemistry.",
        "Cancers and normal mucosa displayed highly significant differences (P < 0.01) in expression of nine genes (MMP-1, -3, -7, -9, -10, -11, -12, -14, and RECK). Primary cancers and metastatic lesions showed highly significant differences (P < 0.01) in MMP-1, -10, -11, and TIMP-1. MMP-12 expression was higher in the primary tumors that were associated without hepatic metastasis than those with metastasis (P < 0.01). High expression of MMP-15 was related to longer disease-free survival (generalized Wilcoxon test, P < 0.0062; Cox hazard model, P < 0.028, hazard ratio, 0.099).",
        "MMP, TIMP, RECK expression patterns may provide an insight into extracellular matrix degrading (which is characteristic of colorectal cancers) and its role in metastasis."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan."
          }
        ],
        "LastName": "Asano",
        "ForeName": "Toshimichi",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Tada",
        "ForeName": "Mitsuhiro",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cheng",
        "ForeName": "Shaoqiang",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Takemoto",
        "ForeName": "Norihiro",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kuramae",
        "ForeName": "Taro",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Abe",
        "ForeName": "Motoki",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Takahashi",
        "ForeName": "Osamu",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Miyamoto",
        "ForeName": "Masaki",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hamada",
        "ForeName": "Jun-Ichi",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Moriuchi",
        "ForeName": "Tetsuya",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kondo",
        "ForeName": "Satoshi",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Surg Res",
    "NlmUniqueID": "0376340",
    "ISSNLinking": "0022-4804"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "GPI-Linked Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Membrane Glycoproteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RECK protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Messenger"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Tissue Inhibitor of Metalloproteinases"
    },
    {
      "RegistryNumber": "EC 3.4.24.-",
      "NameOfSubstance": "Matrix Metalloproteinase 11"
    },
    {
      "RegistryNumber": "EC 3.4.24.-",
      "NameOfSubstance": "Matrix Metalloproteinase 15"
    },
    {
      "RegistryNumber": "EC 3.4.24.-",
      "NameOfSubstance": "Matrix Metalloproteinases"
    },
    {
      "RegistryNumber": "EC 3.4.24.22",
      "NameOfSubstance": "Matrix Metalloproteinase 10"
    },
    {
      "RegistryNumber": "EC 3.4.24.7",
      "NameOfSubstance": "Matrix Metalloproteinase 1"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "metabolism",
        "mortality",
        "pathology"
      ],
      "DescriptorName": "Adenocarcinoma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "metabolism",
        "mortality",
        "pathology"
      ],
      "DescriptorName": "Colorectal Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease-Free Survival"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "GPI-Linked Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "metabolism",
        "secondary"
      ],
      "DescriptorName": "Liver Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Matrix Metalloproteinase 1"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Matrix Metalloproteinase 10"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Matrix Metalloproteinase 11"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Matrix Metalloproteinase 15"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Matrix Metalloproteinases"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Membrane Glycoproteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasm Recurrence, Local"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Predictive Value of Tests"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Proportional Hazards Models"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "RNA, Messenger"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Tissue Inhibitor of Metalloproteinases"
    }
  ]
}